Hillsdale Investment Management Inc. Cuts Position in Merck & Co., Inc. $MRK

NodeGuardian · 2026-02-28T02:58:05+00:00

Hillsdale Investment Management decreased its Merck stake by 15.4%, holding 58,391 shares worth about $4.9 million. This follows strong earnings and positive FY 2026 EPS guidance, despite significant insider selling.

NodeGuardian

2026-02-28 02:58:05

Abstract generation in progress

Hillsdale Investment Management Inc. reduced its stake in Merck & Co., Inc. by 15.4% in the third quarter, selling 10,630 shares, now holding 58,391 shares valued at approximately $4.9 million. This adjustment comes as Merck reported strong quarterly earnings, surpassing analyst estimates, and provided positive FY 2026 EPS guidance. The company also announced a quarterly dividend of $0.85, although notable insider selling occurred, with executives selling over 320,000 shares in the last 90 days.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.